BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36301443)

  • 21. Bupropion in the treatment of major depressive disorder in real-life practice.
    Sennfelt DA; Marques da Silva MA; Tavares AP
    Clin Drug Investig; 2011 Oct; 31 Suppl 1():19-24. PubMed ID: 22015859
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacology of dextromethorphan: Relevance to dextromethorphan/quinidine (Nuedexta®) clinical use.
    Taylor CP; Traynelis SF; Siffert J; Pope LE; Matsumoto RR
    Pharmacol Ther; 2016 Aug; 164():170-82. PubMed ID: 27139517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gepirone Extended-Release: First Approval.
    Keam SJ
    Drugs; 2023 Dec; 83(18):1723-1728. PubMed ID: 38079093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The efficacy and tolerability of bupropion in the treatment of major depressive disorder.
    Moreira R
    Clin Drug Investig; 2011 Oct; 31 Suppl 1():5-17. PubMed ID: 22015858
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Esmethadone-HCl (REL-1017): a promising rapid antidepressant.
    Fava M; Stahl SM; De Martin S; Mattarei A; Bettini E; Comai S; Alimonti A; Bifari F; Pani L; Folli F; Guidetti C; Furlan A; Sgrignani J; Locatelli P; Cavalli A; O'Gorman C; Traversa S; Inturrisi CE; Pappagallo M; Manfredi PL
    Eur Arch Psychiatry Clin Neurosci; 2023 Oct; 273(7):1463-1476. PubMed ID: 36890259
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial.
    Mohamed S; Johnson GR; Chen P; Hicks PB; Davis LL; Yoon J; Gleason TC; Vertrees JE; Weingart K; Tal I; Scrymgeour A; Lawrence DD; Planeta B; Thase ME; Huang GD; Zisook S; ; Rao SD; Pilkinton PD; Wilcox JA; Iranmanesh A; Sapra M; Jurjus G; Michalets JP; Aslam M; Beresford T; Anderson KD; Fernando R; Ramaswamy S; Kasckow J; Westermeyer J; Yoon G; D'Souza DC; Larson G; Anderson WG; Klatt M; Fareed A; Thompson SI; Carrera CJ; Williams SS; Juergens TM; Albers LJ; Nasdahl CS; Villarreal G; Winston JL; Nogues CA; Connolly KR; Tapp A; Jones KA; Khatkhate G; Marri S; Suppes T; LaMotte J; Hurley R; Mayeda AR; Niculescu AB; Fischer BA; Loreck DJ; Rosenlicht N; Lieske S; Finkel MS; Little JT
    JAMA; 2017 Jul; 318(2):132-145. PubMed ID: 28697253
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The combination of duloxetine and bupropion for treatment-resistant major depressive disorder.
    Papakostas GI; Worthington JJ; Iosifescu DV; Kinrys G; Burns AM; Fisher LB; Homberger CH; Mischoulon D; Fava M
    Depress Anxiety; 2006; 23(3):178-81. PubMed ID: 16528701
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bupropion for major depressive disorder: Pharmacokinetic and formulation considerations.
    Jefferson JW; Pradko JF; Muir KT
    Clin Ther; 2005 Nov; 27(11):1685-95. PubMed ID: 16368442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dextromethorphan/bupropion (Auvelity) for depression.
    Med Lett Drugs Ther; 2022 Dec; 64(1666):201-203. PubMed ID: 36542346
    [No Abstract]   [Full Text] [Related]  

  • 30. Esmethadone (REL-1017) and Other Uncompetitive NMDAR Channel Blockers May Improve Mood Disorders via Modulation of Synaptic Kinase-Mediated Signaling.
    Stahl SM; De Martin S; Mattarei A; Bettini E; Pani L; Guidetti C; Folli F; de Somer M; Traversa S; Inturrisi CE; Pappagallo M; Gentilucci M; Alimonti A; Fava M; Manfredi PL
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dextromethorphan/quinidine: AVP 923, dextromethorphan/cytochrome P450-2D6 inhibitor, quinidine/dextromethorphan.
    Drugs R D; 2005; 6(3):174-7. PubMed ID: 15869321
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dextromethorphan: a review of N-methyl-d-aspartate receptor antagonist in the management of pain.
    Siu A; Drachtman R
    CNS Drug Rev; 2007; 13(1):96-106. PubMed ID: 17461892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Involvement of AMPA receptors in the antidepressant-like effects of dextromethorphan in mice.
    Nguyen L; Matsumoto RR
    Behav Brain Res; 2015 Dec; 295():26-34. PubMed ID: 25804358
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Deuterated (d6)-dextromethorphan elicits antidepressant-like effects in mice.
    Nguyen L; Scandinaro AL; Matsumoto RR
    Pharmacol Biochem Behav; 2017 Oct; 161():30-37. PubMed ID: 28916283
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Developing thai economic model to study cost-effectiveness of switching to bupropion compared to combination with bupropion after the failure of an SSRI for major depressive disorder.
    Leelahanaj T
    J Med Assoc Thai; 2010 Nov; 93 Suppl 6():S35-42. PubMed ID: 21284135
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy, tolerability, and acceptability of bupropion for major depressive disorder: a meta-analysis of randomized-controlled trials comparison with venlafaxine.
    Maneeton N; Maneeton B; Eurviriyanukul K; Srisurapanont M
    Drug Des Devel Ther; 2013; 7():1053-62. PubMed ID: 24101861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is antagonism of alpha3beta4 nicotinic receptors a strategy to reduce morphine dependence?
    Taraschenko OD; Panchal V; Maisonneuve IM; Glick SD
    Eur J Pharmacol; 2005 Apr; 513(3):207-18. PubMed ID: 15862802
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of Concurrent Posttraumatic Stress Disorder on Outcomes of Antipsychotic Augmentation for Major Depressive Disorder With a Prior Failed Treatment: VAST-D Randomized Clinical Trial.
    Mohamed S; Johnson GR; Sevilimedu V; Rao SD; Hicks PB; Chen P; Lauro K; Jurjus G; Pilkinton P; Davis L; Wilcox JA; Iranmanesh A; Sapra M; Aslam M; Michalets J; Thase M; Zisook S;
    J Clin Psychiatry; 2020 Jun; 81(4):. PubMed ID: 32603560
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bupropion extended release compared with escitalopram: effects on sexual functioning and antidepressant efficacy in 2 randomized, double-blind, placebo-controlled studies.
    Clayton AH; Croft HA; Horrigan JP; Wightman DS; Krishen A; Richard NE; Modell JG
    J Clin Psychiatry; 2006 May; 67(5):736-46. PubMed ID: 16841623
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Concerns about dextromethorphan as a potential rapid-acting antidepressant.
    Zhou Z; Wu J; Yang C
    Med Hypotheses; 2011 Aug; 77(2):309-10. PubMed ID: 21636217
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.